Sectors

Takeda Ventures and Chiesi Ventures are set to exit the cancer drug developer through the deal, which came after just over $200m in funding.

WuXi AppTec and Juno Therapeutics' joint cancer immunotherapy venture has listed on the Hong Kong Stock Exchange.

New Oriental returned for the educational product developer's series C round, which was led by SoftBank Vision Fund 2.

CU Boulder-founded quantum technology developer ColdQuanta has attracted series A funding to follow a $16.8m seed round closed two years ago.

New Oriental Industrial Fund helped Ronglian (aka Yuntongxun) close a series F round it claimed was the largest yet for a Chinese cloud communication technology producer.

Rakuten Alphabet and Progressive are in line for exits after the automated lending service filed to go public yesterday.

Social game developer Lockwood will use the funding to add more features to its most popular title, which has 200 million registered users.

Gregg Tushaus will manage Corporate Central Credit Union's newly formed fintech investment vehicle, which will invest up to $400,000 per deal.

Global Foundries, Intel, Applied Materials and Lockheed Martin all helped push the optical transceiver technology developer's total funding past $60m.

Venture firm Seventure’s Health For Life Capital Fund II has received a contribution of undisclosed size from Archer Daniels Midland.

Sana Biotechnology has bought central nervous system therapy developer and portfolio company Oscine, which is founded on University of Rochester research.